patsnap.comCrawled Nov 5, 2026
The page presents real-world AI benchmarks for patent tasks, including novelty search and design freedom-to-operate (FTO).
Patsnap provides decision-grade intelligence backed by 20 years of curated data on patents, science, chemistry, and legal records.
Choose a tool below to get a quick answer, then continue into Patsnap Eureka for deeper patent and innovation intelligence when needed.
This article explores the challenges associated with data monetization & the 4 strategies organizations are using to overcome these hurdles.
PatSnap is hosting a series of three webinars, with the first on September 15th at 3pm GMT.
The page explains why combining leading and lagging indicators improves business decision-making beyond patent data alone.
On December 10, 2021, PatSnap’s engineering team was made aware of a potential vulnerability relating to Log4j
Patsnap offers patent, science, and R&D data via APIs, MCP servers, and agent skills, covering 210M+ patents and 300+ endpoints.
The page features 18 women from Patsnap discussing success in Tech and Sales.
Patsnap offers Standard and Premium pricing plans for patent analysis and AI insights, including custom analysis and real-time monitoring.
Patsnap empowers R&D and IP teams with AI-driven insights, accelerating discoveries since 2007.
Patsnap provides AI-driven IP solutions for analyzing data, reducing risk, and protecting patents.
Patsnap’s AI-driven IP analytics and agents boost IP and R&D productivity with 2B+ expert-curated data points.
Patsnap delivers AI-driven patent search, drafting, monitoring, and analytics, accelerating R&D productivity with 2B+ expert data.
Patsnap (UK) Ltd. describes how it uses personal information in litigation, R&D, patent, and inventor records.
The page outlines obligations and permissions for accessing Patsnap’s API.
Patsnap provides legal and compliance resources, including Terms of Use, Privacy Policy, Cookie Policy, and Modern Slavery Statement.
Patsnap Limited Modern Slavery Act Transparency Statement
BenchSci integrates Patsnap’s patent data into its EMET platform, enabling preclinical scientists to assess patent and clinical status of drug targets within a unified research workflow. The partnership combines patent intelligence with drug development tools to streamline scientific decision-making.
Oct 2026benchsci.comNews article
Mark Davies joins Patsnap to oversee life sciences product strategy, leveraging over 20 years of experience in AI-driven drug discovery. His expertise will guide the development of Patsnap’s solutions for pharmaceutical and biotech research. Davies previously worked in data-driven innovation for life sciences applications.
Oct 2026PatsnapNews article
Patsnap’s research identifies a critical patent cliff in oligonucleotide drug development, where one delivery patent expires six years before the drugs it supports. The largest expiry wave occurs in 2034, with 318 patents—including Ionis’s 2'-MOE/LICA antisense chemistry and Alnylam’s GalNAc-siRNA architecture—reaching their 20-year terms.
Sep 2026BioSpaceNews article
Patsnap appoints Matthew Birch, a European patent attorney with over 15 years of intellectual property experience, to lead its AI-powered drafting solutions. Birch will guide the development of agentic drafting tools designed to assist patent professionals. His expertise in IP law aligns with Patsnap’s focus on integrating AI into patent workflows.
Sep 2026PatsnapNews article
